Open Innovation: the ‘New Normal’ in Med Research?
The AstraZeneca website described AstraZeneca’s success in using open innovation. “Collaboration is essential to advancing our understanding of human diseases and accelerating the discovery and development of ground-breaking treatments that benefit patients. Such partnerships can span academic, industry and clinical researchers, all of whom bring unique insights and capabilities to bear on some of the most important questions facing the world today. Companies such as AstraZeneca, with their Open Innovation approach, are providing vital routes to foster innovative partnerships.”
Click here to read the full article.